Skip to content

ERUPT Trial: Urethral scarring after radiation treatment for prostate cancer

ERUPT Trial: External beam Radiotherapy and Urethral strictures in Prostate cancer Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12619000971134
Acronym
ERUPT
Enrollment
73
Registered
2019-07-09
Start date
2020-08-26
Completion date
2024-07-30
Last updated
2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will aim to measure the incidence of urethral strictures that develop after external beam radiotherapy for prostate cancer. Who is it for? You may be eligible for this study if you are an adult with prostate cancer who is undergoing radiotherapy treatment at Icon Cancer Centre Toowoomba QLD, Australia. Study details All participants will need to do is attend an assessment session 6 weeks following the end of radiation therapy treatment and then every 6 months for 5 years. This assessment will involve surveys and a urine flow test that is performed in the clinic. This flow test involves urinating into a flow meter to measure urine flow. It is non-invasive and only takes five to ten minutes to complete. It is hoped that the results from this study will help guide future radiotherapy treatment regimes and aid in the early detection of urethral strictures post-radiotherapy. Thus, leading to a reduction in invasive procedures and decreased overall morbidity. It will also fill the gap in the literature as there are currently no prospective trials on this topic.

Interventions

Uroflow measurements at baseline, 6 weeks post end of radiation therapy treatment and then every 6 months for 5 years post radiation treatment for prostate cancer. AUA surveys completed at baseline, 6 weeks post end of radiation therapy treatment and then every 6 months for 5 years post radiation treatment. Radiation oncologists or a member of the study team will perform uroflow measurements at each follow up appointment and input data into database. Each uroflow measurement takes approximately

Uroflow measurements at baseline, 6 weeks post end of radiation therapy treatment and then every 6 months for 5 years post radiation treatment for prostate cancer. AUA surveys completed at baseline, 6 weeks post end of radiation therapy treatment and then every 6 months for 5 years post radiation treatment. Radiation oncologists or a member of the study team will perform uroflow measurements at each follow up appointment and input data into database. Each uroflow measurement takes approximately 5-10 minutes to complete. This follow up will be performed at the radiation oncology centre in Toowoomba via face-to-face appointments.

Sponsors

Icon Cancer Foundation
Lead SponsorCharities/Societies/Foundations

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All adult men >18 years of age who undergo external beam radiotherapy for prostate cancer between August 2020 and July 2023

Exclusion criteria

Men who have previously had pelvic external beam radiatiotherapy for other cancers Men who have had previous urethral strictures or treatment for urethral strictures.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026